A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2004
11/23/2004	US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004	US6821964 For prophylaxis and therapy of diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation
11/23/2004	US6821962 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases
11/23/2004	US6821961 Monounsaturated fatty acids of at least 20 carbon atoms and perhydrocyclopentanophenanthrene nucleus combination molecules and their use as weight-loss agents
11/23/2004	US6821958 Antiviral composition
11/23/2004	US6821956 Oligodeoxynucleotide decoys for the prophylactic or therapeutic treatment of diseases associated with the binding of endogenous transcription factors to genes involved in cell growth, differentiation and signalling or to viral genes.
11/23/2004	US6821780 Complete nutrient medium for use as a cosmetic and cosmetic use thereof
11/23/2004	US6821731 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis of prostate cancer
11/23/2004	US6821545 Edible, wholly or partially nondigestible low calorie fatty acid polyesters having non-newtonian pseudoplastic rheology at body temperature; substitute for triglyceride fats in low calorie fat-containing foods; for reducing serum cholesterol
11/23/2004	US6821536 Antioxidative compositions
11/23/2004	US6821529 Oligo(ethylene glycol)-terminated 3-alkyl-1,2-dithiolane for use as part of support in chemical analysis
11/23/2004	US6821519 Comprises polypeptide for detecting viral infection; immunoassays; immunostimulant
11/23/2004	US6821510 Administration of a reactive oxygen species (ros) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine)
11/23/2004	CA2432945C Use of doxylamime succinate and pyridoxine hydrochloride for prophylaxis and treatment of post-surgical vomiting
11/23/2004	CA2334527C Combination of selenium-containing compounds with cytostatics
11/23/2004	CA2332087C Aryl substituted azabenzimidazoles and their use in the treatment of hiv and aids related diseases
11/23/2004	CA2329788C Quinoline derivatives
11/23/2004	CA2326970C Acetylene derivatives as anti-inflammatory/analgesic agents
11/23/2004	CA2317106C Method and composition of an oral preparation of itraconazole
11/23/2004	CA2295061C Storage-stable ophthalmic compositions comprising diclofenac and ofloxacin
11/23/2004	CA2294158C Natural antitumor or antiviral substances and use of the same
11/23/2004	CA2265587C Cyanidin compositions and therapeutic and diagnostic uses therefor
11/23/2004	CA2245766C Compositions useful in the phototherapeutic treatment of proliferative skin disorders
11/23/2004	CA2242035C Compositions useful for transferring therapeutically active substances into a target cell, and their use in gene therapy
11/23/2004	CA2231803C Lipid extract having anti-inflammatory activity
11/23/2004	CA2185242C Sustained release tablet containing diclofenac-na
11/23/2004	CA2171446C Pseudo- and non-peptide bradykinin receptor antagonists
11/23/2004	CA2171329C Androstenones
11/23/2004	CA2161346C Sulfonamides and derivatives thereof that modulate the activity of endothelin
11/23/2004	CA2143107C Enantiomerically pure .beta.-d-dioxolane-nucleosides
11/23/2004	CA2135768C Indolocarbazole imides and the use thereof
11/23/2004	CA2125288C Serotoninergic ergoline derivatives
11/23/2004	CA2111662C Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease
11/23/2004	CA2107587C Suppression of thromboxane levels by percutaneous administration of aspirin
11/23/2004	CA2104635C Composition for the treatment of acne containing a salicylic acid derivative, and salicylic acid derivatives
11/23/2004	CA2059052C Phenylimidazolidines, process for their preparation, their application as medicaments and pharmaceutical compositions containing them
11/23/2004	CA2012482C Hepatitis c diagnostics and vaccines
11/22/2004	CA2441681A1 Cancer monitoring and therapeutics
11/18/2004	WO2004100525A2 System and method for blocking television signal having multiple different content ratings
11/18/2004	WO2004099371A2 Methods of treating ischemic related conditions
11/18/2004	WO2004099280A2 Process of making press molded materials using heat activated tertiary amine urethane catalysts
11/18/2004	WO2004099279A2 Heat activated tertiary amine urethane catalysts
11/18/2004	WO2004099230A1 Monosaccharide compounds
11/18/2004	WO2004099229A1 Process for the synthesis of base addition salts of 2,3-0-isopropylidene-1-0-substituted-5,6-dideoxy-5-n- (4-(2-hydroxy-2-oxoethyl)-phenylaminocarbonyl) amino-l-gulofuranosides
11/18/2004	WO2004099215A1 Use of vinca alkaloid and its salt
11/18/2004	WO2004099213A2 Pyrrolo (1,2-b) pyridazine compounds and their use as crf-1 receptor antagonists
11/18/2004	WO2004099208A1 Process for the preparation of famciclovir
11/18/2004	WO2004099202A1 Quinuclidines substituted bentodioxine carboxamides for the treatment of neurodegenerative diseases
11/18/2004	WO2004099188A1 Antitumoral antiadrogenic pyrrolidines
11/18/2004	WO2004099187A1 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
11/18/2004	WO2004099186A1 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
11/18/2004	WO2004099182A1 Zinc salt of (s)-omeprazole
11/18/2004	WO2004099181A1 Barium salt of benzimidazole derivative
11/18/2004	WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
11/18/2004	WO2004099165A2 Heterocyclic compounds and hydro isomers thereof
11/18/2004	WO2004099156A1 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/18/2004	WO2004099155A2 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivates and related compounds as bradykinin b1 receptor antagonists for the treatment of inflamatory diseases
11/18/2004	WO2004099154A2 Pyrazole-amides and sulfonamides as sodium channel modulators
11/18/2004	WO2004099150A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	WO2004099137A1 Aminocyclohexyl ether compounds and uses thereof
11/18/2004	WO2004099134A2 Glutaminyl based dp iv-inhibitors
11/18/2004	WO2004099133A1 2”-hydroxynicotianamine, process for producing the same and angiotensin converting enzyme inhibitor, hypotensive drug and health food
11/18/2004	WO2004099130A2 1,2-diarylimidazoles useful as inhibitors of cox
11/18/2004	WO2004098713A2 Treating cardiovascular diseases with a compound of formula (i) (cs 747 - prasugrel; rn 150322-43-4)
11/18/2004	WO2004098676A2 Novel methods for administration of drugs and devices useful thereof
11/18/2004	WO2004098651A2 Bone localising radiopharmaceutical and tubulin-interacting compound combinatorial radiotherapy
11/18/2004	WO2004098643A1 Compositions containing piperacillin and tazobactam useful for injection
11/18/2004	WO2004098642A1 Migraine relief composition and methods of using and forming same
11/18/2004	WO2004098641A2 A pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
11/18/2004	WO2004098638A1 Effector cell function inhibitor
11/18/2004	WO2004098634A2 Protein arginine n-methyltransferase 2 (prmt-2)
11/18/2004	WO2004098627A1 Inhibition of platelet aggregation through acyclovir and two peptide antagonists
11/18/2004	WO2004098625A2 Medical use of inhibitors of glutaminyl and glutamate cyclases
11/18/2004	WO2004098624A1 Composition comprising bamboo extract and the compounds isolated therefrom showing treating and preventing activity for inflammatory and blood circulation disease
11/18/2004	WO2004098623A1 A notoginseng saponin intravenous injection and the method for preparing this injection
11/18/2004	WO2004098618A2 Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
11/18/2004	WO2004098617A2 Controlled release composition containing a strontium salt
11/18/2004	WO2004098616A1 Method, apparatus, and composition for treating acne
11/18/2004	WO2004098615A1 Pharmaceutical composition for intraarticular application in tendon sheaths and periarticular bursae
11/18/2004	WO2004098614A1 Freeze-dried preparation containing methylcobalamin and process for producing the same
11/18/2004	WO2004098612A2 Calcitriol analogs of uses thereof
11/18/2004	WO2004098611A1 Fortifier
11/18/2004	WO2004098607A1 Pyridinyl acetonitriles
11/18/2004	WO2004098606A1 Composition comprising a pde4 inhibitor and shuil-1r ii
11/18/2004	WO2004098605A1 Pharmaceutical composition comprising a pde4 inhibitor and il-1 trap
11/18/2004	WO2004098603A1 Use of substituted aminoalkanephosphonic acids in the treatment of multiple sclerosis
11/18/2004	WO2004098602A1 Melanocortin receptor-specific compounds
11/18/2004	WO2004098601A1 As a pkc inhibitor, inhibitor for angiogenesis containing 6-anilinoquinoline-5,8-quinone as an effective ingredient
11/18/2004	WO2004098600A1 Positive modulators of nicotinic acetylcholine receptors
11/18/2004	WO2004098599A2 Proton pump inhibitors for the treatment of lower abdominal disorders
11/18/2004	WO2004098598A1 COMPOSITION COMPRISING ROFLUMILAST AND A TNFα ANTAGONIST
11/18/2004	WO2004098597A1 Composition comprising roflumilast and shuil-1r ii
11/18/2004	WO2004098596A1 Composition comprising roflumilast and il-1 trap
11/18/2004	WO2004098595A1 COMPOSITION COMPRISING ROFLUMILAST AND A TNFα ANTAGONIST
11/18/2004	WO2004098594A2 Dosage form containing pantoprazole as active ingredient
11/18/2004	WO2004098593A1 Amorphous clopidogrel hydrogen sulfate composition
11/18/2004	WO2004098592A1 Composition containing oxazolidinone derivative
11/18/2004	WO2004098591A2 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
11/18/2004	WO2004098588A1 Use of sulphonamide derivatives for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion
11/18/2004	WO2004098587A1 Mycophenolate mofetil in diabetic nephropathy

1 ... 4885 4886 4887 4888 4889 4890 4891 4892 4893 4894 4895 4896 4897 4898 4899 4900 4901 4902 4903 4904 4905 ... 7860